Revolutionising lymphoedema treatment - A disruptive technology to improve quality of life

彻底改变淋巴水肿治疗——提高生活质量的颠覆性技术

基本信息

  • 批准号:
    ES/X006360/1
  • 负责人:
  • 金额:
    $ 6.42万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2022
  • 资助国家:
    英国
  • 起止时间:
    2022 至 无数据
  • 项目状态:
    已结题

项目摘要

Clinical problem: Cured of a deadly disease (cancer), but left to survive with a lifelong chronic condition (lymphoedema [LE]). LE is a chronic, progressive, and incurable disease. It is caused by the inability of the lymphatic system (the "plumbing" of the body) to remove fluid from the affected area, resulting in excessive swelling (Fig.1A-B). Risks can include increased age, obesity, and commonly, cancer treatments (e.g., surgery, radiotherapy, chemotherapy). It affects up to 70% of breast, prostate, head and neck cancer patients; they face a lifelong risk of developing lymphoedema, which can manifest from weeks to years after cancer treatment; it is a growing aging challenge and an under-met medical problem.Importance: Growing aging problem with negative impact on quality of life (QoL): with an estimated ~120-250 million individuals globally being affected by LE. It continues to increase with the growing aging population (International Lymphoedema Framework-ILF). It is a leading cause of disability worldwide, yet it remains underdiagnosed, undertreated, under-researched, and underfunded in most healthcare systems, mainly due to lack of awareness from both the public and healthcare professionals (HCP). Lymphoedema patients face huge physical, psychological, and socioeconomic consequences which dramatically reduces their QoL, and significantly affect healthy aging. Physical consequences include: disfigurement, disability, fatigue, pain, excessive swelling. Psychological consequences include: anxiety, depression, decreased self-confidence from distorted body image and loss of independence. Socio-economic consequences include: Huge financial burden (£10K increase in annual treatment), due to the high cost of treatment. (e.g., clinic visits, compression therapy, physiotherapy, several times a week). Lack of productivity due to reduced independence from physical consequences. A new approach is needed: Compression strategies to reduce limb volume such as manual lymphatic drainage (MLD - performed by certified massage therapists), and/or the use of an advanced pneumatic compression device (PCD - delivered at specialist clinics) are critical aspects to treatment, which are viewed as barriers to daily life and described as "terrible daily armour". The lack of an effective way of managing the disease and the inaccessibility of treatment means that this has the most significant effect on patients who are lower income. Proposal: In this project, a new wearable sleeve that is fully portable will be designed, developed, manufactured and tested. The aims of this wearable medical device is to 1) Provide a more sustainable, affordable, and accessible alternative treatment for LE patients, using a needs-led approach 2) Increase LE awareness.My objectives is to : 1) Deliver the world's first portable PCD device - "LymphMotion"; allowing the patient to frequently self-manage their condition, empowering them to have a higher sense of self-autonomy and improve their quality of life. 2) Work with LE stakeholders to provide outreach workshops and increase awareness of lymphoedema and effective management strategies.
临床问题:治愈了致命的疾病(癌症),但留下了终身的慢性疾病(淋巴水肿[LE])。LE是一种慢性、进行性和不可治愈的疾病。它是由淋巴系统(身体的“管道”)不能从受影响的区域移除液体引起的,导致过度肿胀(图1A-B)。风险可能包括年龄增加,肥胖,以及常见的癌症治疗(例如,手术、放疗、化疗)。乳腺癌、前列腺癌、头颈癌患者中有高达70%的人患有淋巴水肿;他们面临着终身淋巴水肿的风险,淋巴水肿可能在癌症治疗后数周至数年内出现;这是一个日益严重的老龄化挑战,也是一个未得到充分解决的医疗问题。重要性:日益严重的老龄化问题对生活质量(QoL)产生负面影响:估计全球约有1.2 - 2.5亿人受LE影响。随着人口老龄化的不断增长,它继续增加(国际脑水肿框架-ILF)。它是全球残疾的主要原因,但在大多数医疗保健系统中,它仍然诊断不足、治疗不足、研究不足和资金不足,这主要是由于公众和医疗保健专业人员(HCP)缺乏认识。脑水肿患者面临巨大的生理、心理和社会经济后果,这大大降低了他们的生活质量,并显著影响健康老龄化。身体后果包括:毁容、残疾、疲劳、疼痛、过度肿胀。心理后果包括:焦虑、抑郁、扭曲的身体形象导致的自信心下降和失去独立性。社会经济后果包括:由于治疗费用高昂,造成巨大的经济负担(每年治疗费用增加1万英镑)。(e.g.,门诊、压迫疗法、物理疗法,每周数次)。由于对身体后果的独立性降低而缺乏生产力。需要采取新的办法:减少肢体体积的压迫策略,如手动淋巴引流(MLD -由认证按摩治疗师执行)和/或使用先进的气动压迫装置(PCD -在专科诊所提供)是治疗的关键方面,被视为日常生活的障碍,并被描述为“可怕的日常盔甲”。缺乏有效的疾病管理方法和无法获得治疗意味着这对低收入患者的影响最大。建议:在该项目中,将设计、开发、制造和测试一种完全便携的新型可穿戴袖子。这个可穿戴医疗设备的目标是1)使用需求导向的方法为LE患者提供更可持续,负担得起和可获得的替代治疗2)提高LE意识。我的目标是:1)提供世界上第一个便携式PCD设备-“LymphMotion”;允许患者经常自我管理他们的病情,使他们能够有更高的自我自主意识,提高他们的生活质量。2)与LE利益相关者合作,提供外展研讨会,提高对淋巴水肿和有效管理策略的认识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katherine Wang其他文献

Precision oncology: mind the disruption
精准肿瘤学:关注颠覆
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Richie Soong;N. Syn;Katherine Wang;M. Omar
  • 通讯作者:
    M. Omar
Social isolation and psychological well‐being among older Chinese Americans: Does resilience mediate the association?
老年华裔美国人的社会孤立和心理健康:复原力是否介导了这种关联?
Surveillance and Isolation of Methicillin-Resistant Staphylococcus aureus Colonization in the Neonatal Intensive Care Unit
新生儿重症监护病房耐甲氧西林金黄色葡萄球菌定植的监测和分离
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Katherine Wang;Coralie Thomas;N. Bhuvanesh;John A Gladysz
  • 通讯作者:
    John A Gladysz
A brain atlas for the camouflaging dwarf cuttlefish, emSepia bandensis/em
伪装矮乌贼(Emperor Dwarf Cuttlefish)的大脑图谱
  • DOI:
    10.1016/j.cub.2023.06.007
  • 发表时间:
    2023-07-10
  • 期刊:
  • 影响因子:
    7.500
  • 作者:
    Tessa G. Montague;Isabelle J. Rieth;Sabrina Gjerswold-Selleck;Daniella Garcia-Rosales;Sukanya Aneja;Dana Elkis;Nanyan Zhu;Sabrina Kentis;Frederick A. Rubino;Adriana Nemes;Katherine Wang;Luke A. Hammond;Roselis Emiliano;Rebecca A. Ober;Jia Guo;Richard Axel
  • 通讯作者:
    Richard Axel
A Cobalt Templated Outer Sphere Hydrogen Bond Donor Catalyst Derived from 2-Guanidinobenzimidazole: Synthesis, Applications in Carbon-Carbon Bond Forming Reactions, Structure
2-胍基苯并咪唑衍生的钴模板化外球氢键供体催化剂:合成、在碳-碳键形成反应中的应用、结构
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Katherine Wang;Coralie Thomas;N. Bhuvanesh;John A Gladysz
  • 通讯作者:
    John A Gladysz

Katherine Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Development of smart medical textiles for treating breast cancer related lymphoedema
开发治疗乳腺癌相关淋巴水肿的智能医用纺织品
  • 批准号:
    EP/W014955/1
  • 财政年份:
    2022
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Research Grant
Related factors of cellulitis history in lymphoedema patients
淋巴水肿患者蜂窝织炎病史的相关因素
  • 批准号:
    18K10307
  • 财政年份:
    2018
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deep phenotyping to improve understanding of causal mechanisms and underlying gene mutations in primary lymphoedema and lymphatic malformations
深度表型分析可提高对原发性淋巴水肿和淋巴管畸形的因果机制和潜在基因突变的理解
  • 批准号:
    MR/P011543/1
  • 财政年份:
    2017
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Research Grant
Dermal and subcutaneous sturucture and skin barrie function for early-stage lymphoedema patients
早期淋巴水肿患者的真皮和皮下结构及皮肤屏障功能
  • 批准号:
    15K21020
  • 财政年份:
    2015
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Reduction of breast lymphoedema symptoms secondary to breast cancer: a randomised controlled trial
减少乳腺癌继发的乳房淋巴水肿症状:一项随机对照试验
  • 批准号:
    nhmrc : 1021608
  • 财政年份:
    2012
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Project Grants
Detection of lymphoedema
淋巴水肿的检测
  • 批准号:
    nhmrc : 1017481
  • 财政年份:
    2011
  • 资助金额:
    $ 6.42万
  • 项目类别:
    NHMRC Postgraduate Scholarships
Clinical Research for EBP of Lymphoedema cure and care
EBP治疗淋巴水肿的临床研究
  • 批准号:
    23390506
  • 财政年份:
    2011
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The evaluation index of the care effect for the lymphoedema
淋巴水肿护理效果评价指标
  • 批准号:
    22792160
  • 财政年份:
    2010
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The role of the lymphangiogenic growth factor VEGF-D in lymphoedema, a common complication of breast cancer surgery
淋巴管生成因子 VEGF-D 在淋巴水肿(乳腺癌手术常见并发症)中的作用
  • 批准号:
    nhmrc : 603143
  • 财政年份:
    2010
  • 资助金额:
    $ 6.42万
  • 项目类别:
    NHMRC Postgraduate Scholarships
Investigation on the present situation and efficient therapeutic approaches on patients with secondary leg lymphoedema.
继发性下肢淋巴水肿患者现状及有效治疗方法探讨
  • 批准号:
    21792208
  • 财政年份:
    2009
  • 资助金额:
    $ 6.42万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了